港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

海西新药

134.800

+2.8002.12%

成交量：3.33万

成交额：442.37万

市值：106.10亿

市盈率：- -

高：135.500

开：132.200

低：130.000

收：132.000

52周最高：147.000

52周最低：97.500

股本：7,870.73万

香港流通股本：7,870.73万

量比：0.33

换手率：0.04%

股息：- -

股息率：- -

净资产收益率：28.75%

总资产收益率：12.62%

市净率：17.93

市盈率(LYR):- -

市销率: 20.79

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

海西新药涨超10%再创新高，较招股价涨近七成！四款核心仿制药贡献九成收入

老虎资讯综合

港股异动 | 海西新药(02637)涨超10%再创新高较招股价涨近七成四款核心仿制药贡献九成收入

海西新药11月10日获主力加仓193.3万元

【IPO月报】10月IPO赚钱效应继续：金叶超购逾万倍长风药业首日可赚万七

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02637"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02637","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","market":"HK","secType":"STK","nameCN":"海西新药","latestPrice":134.8,"timestamp":1763366893757,"preClose":132,"halted":0,"volume":33300,"delay":0,"floatShares":78707270,"shares":78707270,"eps":0,"marketStatus":"已收盘","change":2.8,"latestTime":"11-17 16:08:13","open":132.2,"high":135.5,"low":130,"amount":4423690,"amplitude":0.041667,"askPrice":135.4,"askSize":50,"bidPrice":134.8,"bidSize":100,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":5,"adr":0,"listingDate":1760889600000,"exchange":"SEHK","adjPreClose":132,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"volumeRatio":0.328564,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","floatShares":78707270,"roa":"12.62%","roe":"28.75%","lyrEps":0,"volumeRatio":0.328564,"shares":78707270,"dividePrice":0,"high":135.5,"amplitude":0.041667,"preClose":132,"low":130,"week52Low":97.5,"pbRate":"17.93","psRate":"20.79","week52High":147,"institutionHeld":0,"latestPrice":134.8,"committee":0.333333,"eps":0,"divideRate":0,"volume":33300,"delay":0,"ttmEps":0,"open":132.2,"prevYearClose":86.4,"prevWeekClose":132,"prevMonthClose":119.8,"prevQuarterClose":86.4,"fiveDayClose":129.4,"twentyDayClose":86.4,"sixtyDayClose":86.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02637\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02637\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02637\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02637\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02637","date":"2025-11-14","current":69.713569,"percent":0.842105,"low":41.43616,"twenty":57.493757,"median":61.562796,"eighty":68.778725,"high":76.371175,"avg":61.983096,"sd":7.689241,"marketCap":10389359640},"quantilePoints":[{"date":"2025-10-16","current":41.43616,"twenty":41.43616,"median":41.43616,"eighty":41.43616,"marketCap":6150186077},{"date":"2025-10-24","current":58.044665,"twenty":53.788314,"median":54.742854,"eighty":58.044665,"marketCap":8618446065},{"date":"2025-10-31","current":63.409996,"twenty":54.11413,"median":58.177187,"eighty":60.582738,"marketCap":9429130946},{"date":"2025-11-07","current":65.038519,"twenty":55.071217,"median":59.875924,"eighty":63.533346,"marketCap":9665252756},{"date":"2025-11-14","current":69.713569,"twenty":57.493757,"median":61.562796,"eighty":68.778725,"marketCap":10389359640}],"updateTime":1763367875852},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02637\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1155189587","title":"海西新药涨超10%再创新高，较招股价涨近七成！四款核心仿制药贡献九成收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1155189587","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155189587?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 14:43","pubTimestamp":1762929801,"startTime":"0","endTime":"0","summary":"11月12日，$海西新药$涨超10%再创新高，较招股价涨近七成！公开资料显示，海西新药是一家处于商业化阶段的制药公司。截至招股书披露日，海西新药获批上市的仿制药产品有15款，产品组合涵盖了多个治疗领域，包括消化系统、心血管系统、内分泌系统、神经系统等。从2024年的营收情况看，这四款核心仿制药贡献了海西新药超过九成的收入，达到4.25亿元。值得注意的是，海西新药已布局创新药研发管线。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2e9a463070c3ede9e070dabbce786938","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02637"],"gpt_icon":0},{"id":"2582344262","title":"港股异动 | 海西新药(02637)涨超10%再创新高 较招股价涨近七成 四款核心仿制药贡献九成收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2582344262","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582344262?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 14:36","pubTimestamp":1762929418,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，海西新药午后涨超10%，高见145.9港元，再创上市新高，较招股价86.4港元累涨近70%。公开资料显示，海西新药是一家处于商业化阶段的制药公司。截至招股书披露日，海西新药获批上市的仿制药产品有15款，产品组合涵盖了多个治疗领域，包括消化系统、心血管系统、内分泌系统、神经系统等。从2024年的营收情况看，这四款核心仿制药贡献了海西新药超过九成的收入，达到4.25亿元。值得注意的是，海西新药已布局创新药研发管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2e9a463070c3ede9e070dabbce786938","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02637","BK1191"],"gpt_icon":0},{"id":"2582801415","title":"海西新药11月10日获主力加仓193.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582801415","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582801415?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 16:15","pubTimestamp":1762762523,"startTime":"0","endTime":"0","summary":"11月10日, 海西新药股价涨5.37%，报收129.40元，成交金额1627.1万元，换手率0.16%，振幅7.74%，量比1.10。海西新药今日主力资金净流入193.3万元，连续4日净流入，上一交易日主力净流入169.9万元。该股近5个交易日上涨7.28%，主力资金累计净流入841.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1095.3万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110161643975fcd7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110161643975fcd7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02637"],"gpt_icon":1},{"id":"2580163264","title":"【IPO月报】10月IPO赚钱效应继续：金叶超购逾万倍 长风药业首日可赚万七","url":"https://stock-news.laohu8.com/highlight/detail?id=2580163264","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580163264?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 16:09","pubTimestamp":1762157343,"startTime":"0","endTime":"0","summary":"10月新股IPO数量继续保持高位，认购情绪高涨，金叶国际集团认购倍数超万倍，同时，多只新股上市首日表现亮眼，市场交投活跃度显著提升，为香港资本市场注入新活力。业绩表现方面，10月30日，公司发布前三季度业绩，归属于上市公司股东的净利润约71.36亿元，同比增长46.58%;基本每股收益0.8455元。不过需要注意的是，长风药业在上市后未能延续首日的强劲走势，股价出现接连数日的回吐行情。目前，已获上市委员会批准，待上市数量为19家。","market":"other","thumbnail":"https://static.szfiu.com/news/20220324/YzUxYTE2NDgwOTA4NjcwODA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/YzUxYTE2NDgwOTA4NjcwODA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1968923","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00638","08549","BK1148","BK1191","BK1214","02637","BK1149","06031","06687","BK1171","BK1240","02575","02650","BK1109","02670","02652"],"gpt_icon":1}],"pageSize":4,"totalPage":12,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02637\",params:#limit:6,delay:false,,,undefined,":[]}}